# Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation

> **NCT01282606** · PHASE2 · COMPLETED · sponsor: **Seikagaku Corporation** · enrollment: 18 (actual)

## Conditions studied

- Lumbar Vertebra Hernia

## Interventions

- **DRUG:** SI-6603

## Key facts

- **NCT ID:** NCT01282606
- **Lead sponsor:** Seikagaku Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2012-08
- **Final completion:** —
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282606, "Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01282606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*